Which has grown faster, ASTH or NVCR?

Over the past five years, ASTH grew revenue faster — ASTH at a 53.77% CAGR versus NVCR at 5.12%.

Is ASTH or NVCR more profitable?

ASTH runs the higher net margin — ASTH at 1.05% versus NVCR at -21.25%.

How have ASTH and NVCR total returns compared?

Over the past 10 years, ASTH delivered 25.17% and NVCR delivered 5.67% annualized total return. Past performance doesn't predict future results.

Astrana Health, Inc. (ASTH) vs Novocure Ltd (NVCR)

A side-by-side comparison of Astrana Health, Inc. and Novocure Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ASTH

Astrana Health, Inc.

$1.84B

$37.03HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT

NVCR

Novocure Ltd

$1.83B

$15.68HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT

Total return — ASTH vs NVCR

growth of $100 · dividends reinvested · last 10y

ASTH +824.9% (+24.9%/yr)NVCR +73.5% (+5.7%/yr)ASTH compounded faster over this window

Log scale — wide-divergence pair

ASTH NVCR

ASTH vs NVCR: by the numbers

•ASTH is the larger company ($1.84B vs $1.83B market cap).
•ASTH is profitable (1.05% net margin) while NVCR runs a net loss (-21.25%).
•ASTH grew revenue faster over the past five years (53.77% vs 5.12% CAGR).

Metrics side by side

Valuation

Metric	ASTH	NVCR
P/E ratio	45.30	N/A
Forward P/E	26.49	N/A
P/S ratio	0.48	2.61
P/B ratio	2.21	5.40
EV / EBITDA	13.49	N/A
FCF yield	8.63%	N/A

Profitability

Metric	ASTH	NVCR
Gross margin	9.22%	76.13%
Operating margin	2.61%	-22.08%
Net margin	1.05%	-21.25%
ROE	4.88%	-43.94%
ROIC	4.13%	-26.88%

Growth (annualized)

Metric	ASTH	NVCR
Revenue CAGR (5Y)	53.77%	5.12%
EPS CAGR (5Y)	-15.06%	N/A
FCF CAGR (5Y)	18.35%	N/A
Total return CAGR (5Y)	-16.52%	-32.71%

Frequently asked

Which has grown faster, ASTH or NVCR?: Over the past five years, ASTH grew revenue faster — ASTH at a 53.77% CAGR versus NVCR at 5.12%.
Is ASTH or NVCR more profitable?: ASTH runs the higher net margin — ASTH at 1.05% versus NVCR at -21.25%.
How have ASTH and NVCR total returns compared?: Over the past 10 years, ASTH delivered 25.17% and NVCR delivered 5.67% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ASTH analysis Full NVCR analysis Interactive comparison tool

Dig into the metrics

Astrana Health P/E ratio Astrana Health ROE Novocure ROE Astrana Health operating margin Novocure operating margin Astrana Health revenue growth Novocure revenue growth Astrana Health free cash flow Novocure free cash flow

Astrana Health & Novocure appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.